SLDB Solid Biosciences LLC
Company Analysis
Latest News
🔴 Solid Biosciences is trading 5.6% down amid biotech and broader market pressure
Solid Biosciences is trading at $5.84, down 5.63%, amid weaker biotech sentiment and broader market pressure. - No company-specific announcement explaining...
🟢 Solid Biosciences is trading 6.4% up in pre-market after UBS initiated Buy coverage
Solid Biosciences is trading at $6.30, up +6.42% pre-market amid recent buying following UBS’s initiation of coverage with a Buy rating. - UBS initiated...
🟢 Solid Biosciences rises 5.2% — Biotech Sector Rallies on M&A Activity and Anticipation of Key Cancer Data
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector moved higher, fueled by news that...
🟢 Solid Biosciences is trading 6.69% up in pre-market
Solid Biosciences is trading 6.69% higher in pre-market at $5.90 on October 19, with no verified new company announcement explaining the rise. - Search...
🟢 Solid Biosciences rises 5.3% — Biotech Sector Rallies on Positive Clinical Data and Regulatory News
With Biotech (XBI) up 2.2%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 Solid Biosciences is trading 5% down today as hotter-than-expected CPI lifts rate concerns
Solid Biosciences is trading at $5.53, down 5.07%, amid broader market and biotech-sector pressure. - No verified October 14 company-specific announcement or...
🔴 Solid Biosciences is trading 10.06% down with no company-specific catalyst identified
Solid Biosciences is trading 10.06% down at $6.04, with no fresh company-specific announcement or catalyst identified for October 13, 2026. - A market-news...
🟢 Solid Biosciences is trading 6% up in after-hours trading with no clear company-specific catalyst identified
Solid Biosciences is trading at $7.26, up 5.98% in after-hours trading, with no clear company-specific catalyst identified. - It closed at $6.85 on October 7,...
🔴 Solid Biosciences is trading 5% down with no clear company-specific catalyst identified
Solid Biosciences is trading 5% down at $6.71, with no clear company-specific explanation identified for the October 6 move. - The latest company release...
🟢 Solid Biosciences is trading 13.3% up in pre-market
Solid Biosciences is trading 13.3% up at $8.00 in pre-market on October 6, 2026, versus its October 5 close of $7.06, with no confirmed company-specific...
🟢 Solid Biosciences is trading 5% up with no confirmed company-specific catalyst
Solid Biosciences is trading 5.04% up at $7.20, with no confirmed company-specific catalyst for the move on October 5, 2026. - The company’s investor-relations...
🟢 Solid Biosciences is trading 6.6% up in pre-market
Solid Biosciences is trading at $7.30, up 6.57% in pre-market, with no confirmed company-specific catalyst for the move. - The latest company release found...
🔴 Solid Biosciences is trading 5% down with no confirmed catalyst
Solid Biosciences is trading at $6.90, down 5.22%, with no confirmed reason for the decline. The company’s investor-relations page lists no release dated...
🔴 Solid Biosciences is trading 6.23% down today amid biotech-sector weakness
Solid Biosciences is trading at $7.52, down 6.23%, primarily amid biotech-sector weakness. - XBI is down 2.04% amid broader market selling; higher crude oil...
🔴 Solid Biosciences is trading 10% down today as oil and Treasury yields pressure biotech stocks
Solid Biosciences is trading 10% down at $8.02 as higher crude oil prices and Treasury yields pressure growth-oriented healthcare stocks. - Biotech ETF XBI is...
🔴 Solid Biosciences is trading 5.27% down today; company-specific catalyst unconfirmed
Solid Biosciences is trading at $8.45, down 5.27%, with no verified company-specific catalyst identified for September 23, 2026. • Broader risk-off trading...
🔴 Solid Biosciences is trading 6.49% down in pre-market — catalyst unconfirmed
Solid Biosciences is trading at $8.34 in pre-market, down 6.49%, with the catalyst unconfirmed. - No verified company-specific announcement, earnings release,...
🟢 Solid Biosciences is trading 6.56% up in pre-market
Solid Biosciences is trading 6.56% up at $9.10 after closing at $8.54 on September 21, 2026; no verified company-specific catalyst has been identified. - No...
🟢 Solid Biosciences is trading 5% up in after-hours trading amid broad market risk-on sentiment
Solid Biosciences is trading at $8.97, up 5.08% after closing at $8.54 on September 21, 2026, amid a broader risk-on market backdrop with no verified...
Solid Biosciences Rallies, Cantor Fitzgerald Forecasts Stock Could More Than Double
Cantor Fitzgerald reiterated its Overweight rating on Solid Biosciences on September 16, 2026. The firm increased its price target to $26.00. Analysts suggest...